Haplotype* | The Rotterdam study, ROA | The GARP study, CMC1 OA | |||||
---|---|---|---|---|---|---|---|
Controls† | No DD | DD‡ | Total | Probands | Siblings | ||
(n = 809) | (n = 620) | (n = 163) | (n = 104) | (n = 57) | (n = 47) | ||
*Haplotype frequencies ⩾0.01 in the following order: SNP3 (G>A), SNP5 (C>T), SNP6 (G>A) allowing missing genotype data. | |||||||
†All subjects from the Rotterdam sample. | |||||||
‡Subjects for whom no phenotypic data were available were excluded in the analysis. | |||||||
¶p⩽0.01 v controls (no disc degeneration subjects). | |||||||
§p⩽0.02 v controls. | |||||||
CMC1, first carpometacarpal joint; DD, spinal disc degeneration; DIP, distal interphalangeal joint; GARP, Genetics, Osteoarthritis and Progression study; OA, osteoarthritis; ROA, radiographic osteoarthritis. | |||||||
GCG | 0.608 | 0.607 | 0.599 | 0.545 | 0.565 | 0.521 | |
GCA | 0.003 | 0.005 | 0.001 | 0.005 | 0.000 | 0.011 | |
ACG | 0.167 | 0.169 | 0.169 | 0.157 | 0.146 | 0.170 | |
ACA | 0.209 | 0.211 | 0.200 | 0.283§ | 0.280 | 0.287 | |
ATG | 0.014 | 0.009 | 0.031¶ | 0.010 | 0.009 | 0.011 |